US Patent Application 18316954. GASTRIC RESIDENT ELECTRONICS simplified abstract

From WikiPatents
Jump to navigation Jump to search

GASTRIC RESIDENT ELECTRONICS

Organization Name

Massachusetts Institute of Technology

Inventor(s)

Robert S. Langer of Newton MA (US)

Carlo Giovanni Traverso of Newton MA (US)

Yong Lin Kong of Salt Lake City UT (US)

GASTRIC RESIDENT ELECTRONICS - A simplified explanation of the abstract

This abstract first appeared for US patent application 18316954 titled 'GASTRIC RESIDENT ELECTRONICS

Simplified Explanation

- The patent application describes gastric resident electronics, devices, systems, and methods. - The electronic resident structure is administered orally to a subject and remains inside the subject for at least 24 hours before exiting. - The resident structure is designed for long gastric residence and includes an electronic component. - The structure may also include components for delivering pharmaceutical agents to the subject. - The device has a modular design, combining electronic components with materials that degrade or dissolve to determine when the device exits the subject. - The resident structure is configured to be retained inside the subject for 24 hours or more.


Original Abstract Submitted

Gastric resident electronics, devices, systems, and related methods are generally provided. Some embodiments comprise administering (e.g., orally) an (electronic) resident structure to a subject (e.g., a patient) such that the (electronic) resident structure is retained at a location internal to the subject for a particular amount of time (e.g., at least about 24 hours) before exiting said location internal to the subject. In some embodiments, the resident structure is a gastric resident electronic. That is to say, in some embodiments, the resident structure is configured for relatively long gastric residence and comprises an electronic component. In some embodiments, the structures and components described herein may comprise one or more components configured for the delivery of an active substance(s) (e.g., a pharmaceutical agent) to the subject. In some embodiments, the device has a modular design, combining an electronic component(s) with materials configured for controlled and/or tunable degradation/dissolution to determine the time at which (gastric) residence is lost and the device exits the location internal to the subject. For example, in some embodiments, the resident structure comprises an electronic component and one or more additional components associated with the electronic component such that the resident structure is configured to be retained at a location internal to a subject for greater than or equal to 24 hours.